课题基金 / 基金详情

Urothelial cell response to bacterial infection

Urothelial cell response to bacterial infection
尿路上皮细胞对细菌感染的反应
批准号:
6732071
负责人:
ROBERT Evan HURST
金额:
$14.65万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2006-10-31

项目摘要

项目成果

ROBERT Evan HURST的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):尿路上皮保持一套积极的防御细菌感染。这些包括抑制细菌附着的表面分子形式的静态防御和消除已建立的细菌感染的主动反应。本研究的长期目标是阐明感染调节抗菌防御的机制。我们的假设是,在细菌对抗生素的耐药性不断增加的环境中,理解防御的自然机制应该允许它们的增强作为预防或治疗感染的一种手段,特别是在脆弱人群中。肠球菌属排在细菌性尿路感染的第二位。在该属中普遍存在的高抗生素耐药性使得肠球菌感染的治疗成为治疗挑战。我们实验室以前的研究已经建立了三维生长的膀胱尿路上皮模型,该模型密切模仿膀胱尿路上皮的形态学和功能基因组学。在该模型系统中,可以精确地控制尿路上皮细胞的环境,并且可以添加特定的调节蛋白,或者可以在真实的细胞培养环境中抑制或增强特定基因的作用。我们将提出两个广泛的问题:1。尿道炎对细菌感染有何反应?2.改变尿路上皮中特定基因的表达能调节对细菌感染的反应吗?这种方法将与该合作研究小组其他成员进行的独立细菌和动物模型研究密切结合。我们的模型允许的机制调查中的特定分子的作用,尿路感染的反应可以进行测试。我们这段支持期间的主要目标是扩展我们实验室当前的癌症相关cDNA阵列技术,以研究三维培养中人类尿路上皮细胞在经历肠球菌感染时表达的全基因组变化。我们计划在塑料上使用Clontech系统,该系统由8,000多个命名的人类基因组成。 其目的是根据基因随时间的行为对基因进行聚类,确定参与尿路上皮细胞对感染反应的关键信号传导和反应途径,并学习如何操作和解释大规模基因组数据。这些数据将构成R 01或项目的基本要素,并将允许PI开发新的泌尿外科研究路线。
英文摘要
DESCRIPTION (provided by applicant): The urothelium maintains an active set of defenses against bacterial infection. These include static defenses in the form of surface molecules that inhibit bacterial attachment and active responses to eliminate an established bacterial infection. The long-term aim of this study is to elucidate the mechanisms by which antibacterial defenses are modulated by infection. Our hypothesis is that in an environment of increasing bacterial resistance to antibiotics, understanding the natural mechanisms of defense should permit their augmentation as a means to prevent or treat infection, particularly in vulnerable populations. Enterococcus spp. rank second among the leading cause of bacterial UTIs. The high antibiotic resistance prevalent among this genus makes treatment of enterococcal infections a therapeutic challenge. Previous research in our laboratory has established models for urothelium grown in 3 dimensions that closely mimics both the morphology and functional genomics of the bladder urothelium. In this model system, the environment of the urothelial cells can be controlled precisely and specific modulatory proteins can be added, or the actions of specific genes can be inhibited or augmented in a realistic cell culture environment. We will ask two broad questions: 1. How does the urothelium respond to bacterial infection? 2. Can altering expression of specific genes in the urothelium modulate the response to bacterial infection? This approach will integrate closely with independent bacterial and animal model studies carried out by other members of this collaborative research group. Our model permits mechanistic investigations in which the role of specific molecules in the response of urothelium to infection can be tested. Our main objective for this period of support is to expand on current cancer-related cDNA array technology in our laboratory to investigate genome-wide changes in the expression of human urothelial cells in 3-dimensional culture as they experience infection with enterococcus. We plan to use the Clontech system on plastic consisting of over 8,000 named human genes. The aims are to cluster genes according to their behavior over time, identify the key signaling and response pathways that are involved in the response of urothelial cells to infection, and learn how to manipulate and interpret large-scale genomic data. These data will form an essential element in either an R01 or a program project and will permit the PI to develop a new line of urologic research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SuperGAGs for Intravesicular Treatment of Interstitial Cystitis
  • 批准号:
    10205046
  • 项目类别:
  • 资助金额:
    $126.66万
  • 财政年份:
    2018
  • 负责人:
    ROBERT Evan HURST
  • 依托单位:
The Role of Altered Permeability in Bladder Diseases
The Role of Altered Permeability in Bladder Diseases
The Role of Altered Permeability in Bladder Diseases
海外基金